-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
$25M Bet On This Consumer Cyclical Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
$25M Bet On This Consumer Cyclical Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
The Dow Jones closed lower by over 250 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
EVgo
- The Trade: EVgo, Inc. (NASDAQ:EVGO) Director David Nanus acquired a total 5,882,352 shares an average price of $4.25. To acquire these shares, it cost around $25 million.
- What's Happening: EVgo announced pricing of an offering of Class A common stock.
- What EVgo Does: EVgo owns and operates a public direct current fast charging network in the U.S. EVgo's network of charging stations provides electric vehicle charging infrastructure to consumers and businesses.
HCW Biologics
- The Trade: HCW Biologics Inc. (NASDAQ:HCWB) CFO Rebecca Byam acquired a total of 58,486 shares at an average price of $1.56. The insider spent around $91.08 thousand to buy those shares.
- What's Happening: HCW Biologics posted in-line loss for its first quarter.
- What HCW Biologics Does: HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases.
-
Bioventus
- The Trade: Bioventus Inc. (NASDAQ:BVS) Interim CEO Anthony Bihl III acquired a total of 125,000 shares at an average price of $2.33. To acquire these shares, it cost around $290.99 thousand.
- What's Happening: Bioventus posted better-than-expected quarterly sales.
- What Bioventus Does: Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process.
Check This Out: Top 5 Industrials Stocks That May Collapse In May
Don't forget to check out our premarket coverage here
The Dow Jones closed lower by over 250 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
道琼斯指数周三收盘下跌超过250点。当内部人士购买或出售股票时,这表明他们对公司前景的信心或担忧。对便士股感兴趣的投资者和交易者可以将其视为其整体投资或交易决策中的一个因素。
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
以下是近期一些值得注意的细价股内幕交易。欲了解更多,请查看 本辛加的内幕交易 平台。
EVgo
evGo
- The Trade: EVgo, Inc. (NASDAQ:EVGO) Director David Nanus acquired a total 5,882,352 shares an average price of $4.25. To acquire these shares, it cost around $25 million.
- What's Happening: EVgo announced pricing of an offering of Class A common stock.
- What EVgo Does: EVgo owns and operates a public direct current fast charging network in the U.S. EVgo's network of charging stations provides electric vehicle charging infrastructure to consumers and businesses.
- 交易: evGo, Inc. (纳斯达克股票代码:EVGO)董事戴维·纳纳斯 共收购了 5,882,352 股股票 平均价格为4.25美元。收购这些股票的成本约为2500万美元。
- 发生了什么: EvGo宣布了A类普通股发行的定价。
- evgo 会做什么: evGo 在美国拥有并运营公共直流快速充电网络。evGo 的充电站网络为消费者和企业提供电动汽车充电基础设施。
HCW Biologics
HCW Biologics
- The Trade: HCW Biologics Inc. (NASDAQ:HCWB) CFO Rebecca Byam acquired a total of 58,486 shares at an average price of $1.56. The insider spent around $91.08 thousand to buy those shares.
- What's Happening: HCW Biologics posted in-line loss for its first quarter.
- What HCW Biologics Does: HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases.
-
Bioventus
- The Trade: Bioventus Inc. (NASDAQ:BVS) Interim CEO Anthony Bihl III acquired a total of 125,000 shares at an average price of $2.33. To acquire these shares, it cost around $290.99 thousand.
- What's Happening: Bioventus posted better-than-expected quarterly sales.
- What Bioventus Does: Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process.
- 这笔交易: HCW Biologics Inc. (纳斯达克股票代码:HCWB)首席财务官丽贝卡·拜亚姆 共收购了58,486股股票 平均价格为1.56美元。内部人士花费了约91.08万美元购买这些股票。
- 发生了什么:HCW Biologics公布了第一季度的在线亏损。
- HCW Biologics 是做什么的: HCW Biologics Inc是一家处于临床阶段的生物制药公司,专注于发现和开发新的免疫疗法,通过打破慢性、低度炎症与年龄相关疾病之间的联系来延长健康寿命。
-
生物文图斯
- 这笔交易: Bioventus Inc. (纳斯达克股票代码:BVS)临时首席执行官安东尼·比尔三世 共收购了12.5万股股票 平均价格为2.33美元。收购这些股票的成本约为290.99万美元。
- 发生了什么:Bioventus公布的季度销售额好于预期。
- Bioventus 在做什么: Bioventus Inc是一家医疗技术公司。该公司正在开发和商业化临床差异化疗法,这些疗法涉及和增强人体的自然愈合过程。
Check This Out: Top 5 Industrials Stocks That May Collapse In May
看看这个: 五月份可能暴跌的五大工业股
Don't forget to check out our premarket coverage here
别忘了在这里查看我们的上市前报道
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧